PEAK6 Group’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$90K Sell
2,000
-1,200
-38% -$47.9K ﹤0.01% 3741
2018
Q1
$99K Sell
3,200
-23,900
-88% -$786K ﹤0.01% 3721
2017
Q4
$810K Sell
27,100
-29,700
-52% -$860K ﹤0.01% 2083
2017
Q3
$1.87M Sell
56,800
-33,400
-37% -$1.16M 0.01% 1448
2017
Q2
$3.02M Sell
90,200
-106,600
-54% -$3.18M 0.02% 1038
2017
Q1
$5.7M Buy
196,800
+116,500
+145% +$2.89M 0.05% 517
2016
Q4
$1.79M Buy
80,300
+37,100
+86% +$725K 0.01% 1401
2016
Q3
$802K Sell
43,200
-600
-1% -$11.3K 0.01% 1968
2016
Q2
$714K Buy
+43,800
New +$644K 0.01% 2074
2016
Q1
Sell
-9,400
Closed -$110K 5602
2015
Q4
$110K Sell
9,400
-42,400
-82% -$536K ﹤0.01% 3906
2015
Q3
$634K Buy
51,800
+27,200
+111% +$347K ﹤0.01% 2655
2015
Q2
$232K Buy
24,600
+19,500
+382% +$180K ﹤0.01% 3567
2015
Q1
$45K Buy
+5,100
New +$51.5K ﹤0.01% 4311
2014
Q3
Sell
-7,500
Closed -$54K 5688
2014
Q2
$54K Buy
+7,500
New +$59.7K ﹤0.01% 4034

Other funds holding BEAT

PEAK6 Group's BEAT Position: Q2 2018 in Review

PEAK6 Group sold out of BioTelemetry, Inc. (BEAT) in Q2 2018, closing a stake of 26,367 shares — an estimated $1.05M sold.

PEAK6 Group first reported a position in BEAT in Q2 2013 and held it in 7 quarters. The position peaked at $819K in Q1 2018. 227 funds tracked by Wall St. Rank hold BEAT as of Q2 2018.

  • PEAK6 Group reported no remaining BioTelemetry, Inc. position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 26,367 BioTelemetry, Inc. shares in Q2 2018, an estimated $1.05M.
  • PEAK6 Group first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 7 quarters.
  • PEAK6 Group's BioTelemetry, Inc. position peaked at $819K in Q1 2018.
  • 227 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.